The researchers found that dry powder triple inhaler therapy of fluticasone-umeclidinium-vilanterol resulted in fewer COPD exacerbations compared to metered dose triple inhaler therapy of ...
The other single-inhaler on the market for COPD triple therapy, fluticasone-umeclidinium-vilanterol, is a dry-powder inhaler that does not contain hydrofluoroalkane-134a. In a 2024 JAMA report ...
a twice-daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score ...
Inhalers come in three main types: metered-dose inhaler (MDI) dry powder inhaler (DPI) soft mist inhaler (SMI) Keep reading to learn about each type of inhaler, including the medications available ...
Seretide (salmeterol xinafoate/fluticasone propionate ... However, Seretide is available both as a pMDI and in the Diskus dry powder inhaler, and is also approved for patients with chronic ...
The abbreviated new drug application (ANDA) for the fluticasone propionate and salmeterol inhalation powder ... through Vectura's patented dry powder formulation technology.
Objective: To compare the pharmacokinetic profile and bioavailability of budesonide after inhalation from the Clickhaler® dry powder inhaler with the Turbuhaler® as standard. Design: Randomised ...